The Effect of Immune Cell-derived Exosomes in the Cardiac Tissue Repair After Myocardial Infarction: Molecular Mechanisms and Pre-clinical Evidence
Overview
Molecular Biology
Authors
Affiliations
After a myocardial infarction (MI), the inflammatory responses are induced and assist to repair ischaemic injury and restore tissue integrity, but excessive inflammatory processes promote abnormal cardiac remodelling and progress towards heart failure. Thus, a timely resolution of inflammation and a firmly regulated balance between regulatory and inflammatory mechanisms can be helpful. Molecular- and cellular-based approaches modulating immune response post-MI have emerged as a promising therapeutic strategy. Exosomes are essential mediators of cell-to-cell communications, which are effective in modulating immune responses and immune cells following MI, improving the repair process of infarcted myocardium and maintaining ventricular function via the crosstalk among immune cells or between immune cells and myocardial cells. The present review aimed to seek the role of immune cell-secreted exosomes in infarcted myocardium post-MI, together with mechanisms behind their repairing impact on the damaged myocardium. The exosomes we focus on are secreted by classic immune cells including macrophages, dendritic cells, regulatory T cells and CD4 T cells; however, further research is demanded to determine the role of exosomes secreted by other immune cells, such as B cells, neutrophils and mast cells, in infarcted myocardium after MI. This knowledge can assist in the development of future therapeutic strategies, which may benefit MI patients.
Feng Y, Wang Y, Li L, Yang Y, Tan X, Chen T Int J Nanomedicine. 2024; 19:10605-10621.
PMID: 39445157 PMC: 11498042. DOI: 10.2147/IJN.S476995.
TRAF3IP3 Blocks Mitophagy to Exacerbate Myocardial Injury Induced by Ischemia-Reperfusion.
Wei Z, Liu J, Liu H, Jiang A Cardiovasc Toxicol. 2024; 24(11):1204-1214.
PMID: 39240426 DOI: 10.1007/s12012-024-09916-8.
Detailed role of mesenchymal stem cell (MSC)-derived exosome therapy in cardiac diseases.
Hassanzadeh A, Shomali N, Kamrani A, Nasiri H, Heris J, Pashaiasl M EXCLI J. 2024; 23:401-420.
PMID: 38741729 PMC: 11089093. DOI: 10.17179/excli2023-6538.
Gong Z, Xiong Y, Ning Y, Tang R, Xu J, Jiang W Int J Nanomedicine. 2024; 19:2005-2024.
PMID: 38469055 PMC: 10926597. DOI: 10.2147/IJN.S441307.
Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus.
Zheng W, Ji X, Yin Q, Wu C, Xu C, Pan H J Diabetes Res. 2024; 2024:3759339.
PMID: 38455849 PMC: 10919986. DOI: 10.1155/2024/3759339.